Literature DB >> 25512646

Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD.

Yi-Chun Tsai1, Yi-Wen Chiu2, Jer-Chia Tsai2, Hung-Tien Kuo2, Chi-Chih Hung2, Shang-Jyh Hwang3, Tzu-Hui Chen4, Mei-Chuan Kuo5, Hung-Chun Chen2.   

Abstract

BACKGROUND AND OBJECTIVES: Fluid overload is a common characteristic associated with renal progression in CKD. Additionally, fluid overload is an independent predictor of all-cause or cardiovascular mortality in patients on dialysis, but its influence on patients not on dialysis is uncertain. The aim of the study was to assess the relationship between the severity of fluid status and clinical outcomes in an advanced CKD cohort. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In total, 478 predialysis patients with stages 4 and 5 CKD in the integrated CKD care program were enrolled from January of 2011 to December of 2011 and followed-up until August of 2013. The clinical outcomes included cardiovascular morbidity and all-cause mortality. The relative hydration status (overhydration/extracellular water) was used as the presentation of the severity of fluid status and measured using a body composition monitor. Overhydration/extracellular water >7% was defined as fluid overload.
RESULTS: Over a median follow-up period of 23.2 (12.6-26.4) months, 66 (13.8%) patients reached all-cause mortality or cardiovascular morbidity. The adjusted hazard ratio of the combined outcome of all-cause mortality or cardiovascular morbidity for every 1% higher overhydration/extracellular water was 1.08 (95% confidence interval, 1.04 to 1.12; P<0.001). The adjusted overhydration/extracellular water for the combined outcome of all-cause mortality or cardiovascular morbidity in participants with overhydration/extracellular water ≥7% compared with those with overhydration/extracellular water <7% was 1.93 (95% confidence interval, 1.01 to 3.69; P=0.04). In subgroup analysis, higher overhydration/extracellular water was consistently associated with increased risk for the combined outcome independent of diabetes, cardiovascular disease, and serum albumin. There was no significant interaction between all subgroups.
CONCLUSIONS: These findings suggest that fluid overload is an independent risk factor of the combined outcome of all-cause mortality or cardiovascular morbidity in patients with advanced CKD.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  CKD; cardiovascular disease; mortality

Mesh:

Year:  2014        PMID: 25512646      PMCID: PMC4284411          DOI: 10.2215/CJN.03610414

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  42 in total

1.  [Relation of hypoxia and edema of the intestinal wall and skin to colloid osmotic pressure].

Authors:  P Lundsgaard-Hansen; B Blauhut
Journal:  Anaesthesist       Date:  1988-02       Impact factor: 1.041

2.  Importance of whole-body bioimpedance spectroscopy for the management of fluid balance.

Authors:  Peter Wabel; Paul Chamney; Ulrich Moissl; Tomas Jirka
Journal:  Blood Purif       Date:  2009-01-23       Impact factor: 2.614

3.  BNP directly immunoregulates the innate immune system of cardiac transplant recipients in vitro.

Authors:  S M Shaw; J E Fildes; C M Puchałka; M Basith; N Yonan; S G Williams
Journal:  Transpl Immunol       Date:  2008-09-21       Impact factor: 1.708

4.  Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients.

Authors:  Volker Wizemann; Christiane Rode; Peter Wabel
Journal:  Contrib Nephrol       Date:  2008       Impact factor: 1.580

Review 5.  Roles of the kidneys and fluid volumes in arterial pressure regulation and hypertension.

Authors:  A C Guyton
Journal:  Chin J Physiol       Date:  1989       Impact factor: 1.764

6.  Wall stress and patterns of hypertrophy in the human left ventricle.

Authors:  W Grossman; D Jones; L P McLaurin
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

7.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 8.  Arterial stiffness and kidney function.

Authors:  Michel E Safar; Gérard M London; Gérard E Plante
Journal:  Hypertension       Date:  2004-01-19       Impact factor: 10.190

9.  Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study.

Authors:  Yi-Chun Tsai; Jer-Chia Tsai; Szu-Chia Chen; Yi-Wen Chiu; Shang-Jyh Hwang; Chi-Chih Hung; Tzu-Hui Chen; Mei-Chuan Kuo; Hung-Chun Chen
Journal:  Am J Kidney Dis       Date:  2013-07-26       Impact factor: 8.860

Review 10.  Cardiorenal syndrome.

Authors:  Claudio Ronco; Mikko Haapio; Andrew A House; Nagesh Anavekar; Rinaldo Bellomo
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more
  45 in total

1.  Is fluid overload as measured by bioimpedance spectroscopy harmful in CKD-if so, why?

Authors:  Lee A Hebert; Samir Parikh
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-15       Impact factor: 8.237

2.  Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Managing Volume Overload.

Authors:  Carmine Zoccali; Francesca Mallamaci
Journal:  Clin J Am Soc Nephrol       Date:  2018-08-15       Impact factor: 8.237

3.  Application of bioimpedance spectroscopy in Asian dialysis patients (ABISAD-III): a randomized controlled trial for clinical outcomes.

Authors:  Chen Huan-Sheng; Chang Yeong-Chang; Hsieh Ming-Hsing; Tseng Fan-Lieh; Lin Chu-Cheng; Wu Tsai-Kun; Chen Hung-Ping; Hung Sze-Hung; Chiu Hsien-Chang; Lee Chia-Chen; Hou Chun-Cheng; Cheng Chun-Ting; Liou Hung-Hsiang; Lin Chun-Ju; Lim Paik-Seong
Journal:  Int Urol Nephrol       Date:  2016-09-12       Impact factor: 2.370

Review 4.  Using Bioimpedance Spectroscopy to Assess Volume Status in Dialysis Patients.

Authors:  Frank M van der Sande; Esther R van de Wal-Visscher; Stefano Stuard; Ulrich Moissl; Jeroen P Kooman
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

5.  Is overhydration in peritoneal dialysis patients associated with cardiac mortality that might be reversible?

Authors:  Elizabeth Oei; Klara Paudel; Annemarie Visser; Hazel Finney; Stanley L Fan
Journal:  World J Nephrol       Date:  2016-09-06

6.  Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients.

Authors:  Takahiro Masuda; Ken Ohara; Izumi Nagayama; Ryo Matsuoka; Takuya Murakami; Saki Nakagawa; Kentanro Oka; Maki Asakura; Yusuke Igarashi; Yukimura Fukaya; Yasuharu Miyazawa; Akito Maeshima; Tetsu Akimoto; Osamu Saito; Daisuke Nagata
Journal:  Int Urol Nephrol       Date:  2019-06-03       Impact factor: 2.370

Review 7.  Revisiting diuretic choice in chronic kidney disease.

Authors:  Sehrish Ali; Sankar D Navaneethan; Salim S Virani; L Parker Gregg
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-07-11       Impact factor: 3.416

8.  The effect of ambient temperature and humidity on interdialytic weight gains in end-stage renal disease patients on maintenance hemodialysis.

Authors:  Mihály B Tapolyai; Mária Faludi; Klára Berta; Tibor Szarvas; Zsolt Lengvárszky; Miklos Z Molnar; Neville R Dossabhoy; Tibor Fülöp
Journal:  Int Urol Nephrol       Date:  2016-04-28       Impact factor: 2.370

9.  The comparison of clinical outcomes in patients with acute myocardial infarction and advanced chronic kidney disease on chronic hemodialysis versus off hemodialysis.

Authors:  Naoyuki Akashi; Kenichi Sakakura; Yusuke Watanabe; Masamitsu Noguchi; Yousuke Taniguchi; Kei Yamamoto; Hiroshi Wada; Shin-Ichi Momomura; Hideo Fujita
Journal:  Heart Vessels       Date:  2018-01-16       Impact factor: 2.037

10.  Impact of extracellular-to-intracellular fluid volume ratio on albuminuria in patients with type 2 diabetes: A cross-sectional and longitudinal cohort study.

Authors:  Hanako Nakajima; Yoshitaka Hashimoto; Ayumi Kaji; Ryosuke Sakai; Fuyuko Takahashi; Yuta Yoshimura; Ryo Bamba; Takuro Okamura; Noriyuki Kitagawa; Saori Majima; Takufumi Senmaru; Hiroshi Okada; Naoko Nakanishi; Emi Ushigome; Mai Asano; Masahide Hamaguchi; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Diabetes Investig       Date:  2020-11-28       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.